Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
B-cell therapy biotech Walking Fish closes down
Walking Fish CEO Rusty Williams said the biotech was on the precipice of raising more capital before a key internal investor backed out.
Max Bayer
May 7, 2024 5:30pm
Fierce Biotech Fundraising Tracker: Zenas, Reunion & more
May 7, 2024 8:00am
Zenas bags $200M series C to reach a handful of key mAB readouts
May 7, 2024 7:00am
'Next wave of IPOs' will arrive in summer, predicts VC partner
May 3, 2024 10:49am
BridgeBio taps VCs for $200M to fund cancer-focused spinout
May 2, 2024 7:00am
Reunion nets $103M, one of the largest for a psychedelic biotech
May 2, 2024 6:30am